Background The role of inflammation-related markers in alpha-fetoprotein (AFP) negative
hepatocellular carcinoma (HCC) is not well known. This study aimed to investigate the …

Background The prognosis of hepatocellular carcinoma (HCC) is not optimistic. Our study
focused on present inflammatory markers, including the neutrophil-to-lymphocyte ratio …

Background and aim Prognosis determination is essential for hepatocellular carcinoma
(HCC) patient management and treatment planning. The current study aimed to evaluate the …

Aim To investigate the prognostic value of the preoperative albumin–lymphocyte–platelet–C‐
reactive protein (ALPC) index in patients with hepatocellular carcinoma (HCC) undergoing …

Objectives Various inflammation-based prognostic scores have been associated with poor
survival in patients with hepatocellular carcinoma (HCC), and neutrophils display important …

Background: Inflammatory markers are regarded as prognostic factors of the outcomes of
hepatocellular carcinoma (HCC). Examples include the neutrophil-to-lymphocyte ratio …

Background Various inflammation‐based prognostic scores, including the G lasgow
prognostic score (GPS), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio …

Purpose Inflammation factors affect the prognosis of hepatocellular carcinoma (HCC).
However, it is not clear if the preoperative neutrophil lymphocyte ratio to albumin ratio …

Background Various preoperative inflammatory indicators have been identified as potential
predictors of poor prognosis in patients with hepatocellular carcinoma (HCC), but the role of …

Inflammation plays an important role in cancer progression. In this study, we aimed to
investigate the prognostic value of the systemic inflammatory biomarkers in hepatocellular …